Research suggests that CASC2 can sensitize cancer cells to chemotherapeutic agents, making it a promising target for enhancing treatment efficacy The expression levels of p53, MEG3, CASC2, and PANDA were significantly lower in tumor samples compared to non - tumor samples. This evidence concerns the gene MEG3 and neoplasm.